Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So there we have it. Establishing partnerships for B-OM and B-IBD and partnerships for Kevetrin in the EMA. Interested parties for B and K. It's coming.
Lying on a beach somewhere?
The 25 cents was the kill funding target to aim for. Mission accomplished leaving Ipix severely wounded.
That great big target of 25 cents where the Aspire funding died is where Leo miscalculated. It was also a target for all shorters, hedgies, and manipulators to bash the stock to where he could no longer tap funds. They knew what they were doing and Leo could do nothing about it. It was never about the science so now we have to hope the science is good enough to get us out of this mess. Brilacidin certainly looks good for some type of deal. Go Brilacidin.
Are you trying to say there is something worse than abandonment? Ridiculous.
Just another dirty little dig at Leo imo.
The Company expects to release....nothing firm and no specific timeline. We got most of it on December 17th.
I don't see any reason whatsoever for you to continue muddying the water.
the December 17th pr gave us the very exciting news that Brilacidin-OM has a pathway to Phase 3. If that was a requirement of a potential partner we got it. All good news. The point being we got what we wanted and it's all the company wants to tell us for now. Nothing more, nothing less. No need for a federal enquiry and no need to cast doubt.
Said it before and still have the same view that nothing will be announced about the fda minutes until a partnership is announced.
An unwatched pot overboils!?
I am over ready for a deal. I will take anything that gives Ipix and it's shareholders the opportunity to reap large gains. That includes taking K to the level of knowing it's partnership material or a failure. Go Leo.
Gnashing of teeth over the Prurisol era is pointless right now as the company directs it’s focus towards partnership(s).
There are multiple companies interested yet you say chuck it in. Wow! Now I wonder why.
Do you know if Menon was "asked" to give up his holdings etc.,
Years of negative and anti Leo comments at a time when the company was working diligently to progress their platform certainly has taken its toll on the sp and this board. Simply, unscrupulous behavior by the unscrupulous. Good for Leo keeping confident, after all, he has the wisdom of Bertolino and the inside knowledge of how truly exciting Brilacidin is. He owns the truth the unscrupulous own the lies.
A state of emergency like the weather you are experiencing right now?
I think you would take a partner from Europe if one came along.
Whiff of an in hours announcement maybe? Or buyers looking for a bargain on the buy recommendation?
Is Brilacidin for om and ibd advanced enough to get the money? if so it's third time lucky for the bloggers recommendations, and probably enough to put all his buys in plus land. Ipix has a chance so constantly writing them off seems very premature to me.
The people who took Ipix down below 25 cents knew how bad that would be for Ipix. IMO that has been an obvious target for no other reason than to hurt the company and enrich those doing it.
What I learned is that it is not necessary to make a whole federal case over the timing of more input re the eop 2 meeting.
They got clear guidance from the FDA for a Phase 3 clinical trial and obviously until they have a partner we won't know those details.
The company is preparing the way for a European partnership and is doing as much as it can without expending too much money. That’s the way I see it and, of course, if the announcement had come with a joint venture it would have been terrific. It didn’t so the waiting continues. I believe that the eop phase 2 fda meeting has been fairly fully discussed and am not expecting more until a partnership is consummated. The CEO is under terrific pressure to get something done before going back to the well for more money. He put himself in this position and he knows what he has to do. Let’s hope he does it as Brilacidin is a serious candidate for partnership.
I don't have to read any of Leo's past press releases as I am fully aware of his jargon. And it is not a question of being over excited at the current pr but it is good to know we have a chance to make a deal and progress Ipix into the future.
Seems likely we have more than one interested party but both are playing hardball. But, then again, are we not very close because we are setting up an European subsidiary? Looks good to me.
Maybe Leo is frightened some entity will try to steal Ipix. (too cheaply)
So Leo has interest for B-OM and B-IBD together or separately. Maybe from different parties at less than his optimum price. Maybe he can get financing to cover the amount he's short and put Ipix in a better position for the next license.
Why don't you explain it and we can then express our opinions one way or another.
I think there is serious interest in Brilacidin and the sp doesn’t reflect it. More good news to come.
I believe that what the company has already announced is pretty much it.
That's right.
You should try answering that yourself. Do they believe K will eventually be a massive winner, after all this is why he got his shares in the first place? Maybe they just don't see the gloom that you present.
The complainers may well be buyers not sellers as they know Brilacidin is a potential blockbuster and worth many times the market cap.
Looking forward to the time Ipix will make the announcement everybody wants to see.
Yes I would like to know how Ipix will pay for this trial but it doesn't necessarily mean they don't have that covered.
It's v cheap.
Is something wrong here?
The only person the Aruda's are laughing at is you.
This game is for grown ups only as investing in biotechnology stocks is unsuitable for most and not for the faint of heart.
Not worth the discussion.
An untapped market with FDA clearance for stage 3 clinical trials seems an exciting prospect in my book. Very exciting.
Leo needs to take his time, find the right way to move Ipix forward without major dilution. We have an excellent product in Brilacidin to make it really big(ly) and we can all get out of this whole. The amount of panic by some is astounding given the type of investment this is.